21 C.F.R. § 1.1410

When will FDA consider whether to waive a requirement of this subpart?

Last amended: 2023Year: 2026Length: 62 wordsSubsections: 2Official source

Cite as 21 C.F.R. § 1.1410 (2026)

FDA will consider whether to waive a requirement of this subpart on our own initiative or in response to the following: (a) A written request for a waiver for an individual entity; or (b) A citizen petition requesting a waiver for a type of entity submitted under § 10.30 of this chapter by any person subject to the requirements of this subpart.
Cross-references to the CFR
10.30
21 C.F.R. § 1.1410: When will FDA consider whether to waive a requirement of this subpart? | Justis AI